Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.